Lakewood, Colorado, USA (PRWEB) October 19, 2016
Terumo BCT will exhibit apheresis collection and blood processing technologies at the annual AABB 2016 Meeting, a premier event targeting blood center and hospital professionals interested in advancing transfusion and cell therapy.
22 to 25 October 2016
AABB 2016
Orange County Convention Center
Orlando, FL
Terumo BCT Booth #937–West Hall E and F
As a key meeting sponsor and global leader in this area, Terumo BCT will participate in CME sessions, host a symposium and demonstrate its technologies at AABB 2016. Innovations on display in the booth #937 include:
Trima Accel® Automated Blood Collection System–The world’s leading apheresis collection device and the only system on the market today that can collect any transfusable component, in any combination, helping blood centers better meet the demand for blood in their communities. The device can be used for in-center collections or on mobile drives and is supported by a range of innovative business intelligence and operational software that helps drive efficiencies and quality.
Spectra Optia® Apheresis System–The industry's next-generation therapeutic apheresis and cell collection platform designed to help operators spend more time focusing on patient care.
Terumo BCT Suite of Software Solutions–Innovative technologies that help customers harness the power of connectivity and real-time data, providing visibility into a blood center’s collection and processing procedures.
Terumo BCT is an exclusive authorized distributor of B Medical Systems biomedical refrigeration products in the United States and Canada. Please visit B Medical Systems at booth #1044 for product demonstrations.
Other Terumo BCT activities taking place throughout the course of the meeting are as follows:
THURSDAY, 20 OCTOBER
1:00 p.m.
Room W230 A/B
Orange County Convention Center
Pre-Conference Workshop: (HEMO) Hemovigilance Workshop: Learn How Hemovigilance is Practiced in the U.S. and How Hospitals Can Participate
Palani Palaniappan, Executive Vice President,Innovation & Development - Terumo BCT
“Safety Innovations and Hemovigilance: Broad Perspectives on Enabling Technologies”
SUNDAY, 23 OCTOBER
7:00 a.m.
Room W240
Orange County Convention Center
Breakfast Symposium: Bringing Value to Your Blood Center: The Potential of Apheresis Therapies
Richard Smith, Global Clinical Scientist, Terumo BCT
"Apheresis Optimization for Immunotherapy Collections”
Ross Fasano, MD
Assistant Professor, Pathology & Laboratory Medicine, Emory University School of Medicine
“Value of Red Blood Cell Exchange for Sickle Cell Disease Patients and the Impact to Blood Centers”
Heather Pidcoke, MD, PhD Director, Global Clinical Safety & PRT Scientific Affairs, Terumo BCT
“Update on Pathogen Reduction Activities”
About Terumo BCT
Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, is the only company with the unique combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction technologies. We believe in the potential of blood to do even more for patients than it does today. This belief inspires our innovation and strengthens our collaboration with customers.